» Authors » John R Crouse 3rd

John R Crouse 3rd

Explore the profile of John R Crouse 3rd including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 1549
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao X, Sun J, Hippe D, Isquith D, Canton G, Yamada K, et al.
Circ Cardiovasc Imaging . 2022 Nov; 15(11):e014229. PMID: 36378778
Background: Intraplaque hemorrhage (IPH) is associated with plaque progression and ischemic events, and plaque lipid content (% lipid core) predicts the residual atherosclerotic cardiovascular disease risk. This study examined the...
2.
Sun J, Zhao X, Balu N, Neradilek M, Isquith D, Yamada K, et al.
JACC Cardiovasc Imaging . 2017 Mar; 10(3):241-249. PMID: 28279371
Objectives: The aim of this study was to investigate whether and what carotid plaque characteristics predict systemic cardiovascular outcomes in patients with clinically established atherosclerotic disease. Background: Advancements in atherosclerosis...
3.
Sarkar S, Terry J, Ikizler T, Crouse 3rd J, Carr J, Hung A
Obes Res Clin Pract . 2016 Sep; 10(5):613-615. PMID: 27670349
No abstract available.
4.
Zhao X, Hatsukami T, Hippe D, Sun J, Balu N, Isquith D, et al.
Am J Cardiol . 2014 Sep; 114(9):1412-9. PMID: 25245415
Association between clinical factors and high-risk plaque features, such as, thin or ruptured cap, intraplaque hemorrhage, presence of lipid-rich necrotic core (LRNC), and increased LRNC volume as assessed by magnetic...
5.
Lind L, Peters S, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, et al.
J Am Soc Echocardiogr . 2012 Aug; 25(10):1120-1127.e1. PMID: 22884641
Background: The echolucency of the carotid intima-media is related to increased cardiovascular risk factor levels, morbidity, and mortality. The aim of this study was to assess the effect of statins...
6.
Peters S, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, OLeary D, et al.
Curr Med Res Opin . 2012 Apr; 28(6):891-9. PMID: 22536884
Objective: Carotid intima-media thickness (CIMT) is a marker of atherosclerosis that is commonly used to assess the effect of therapeutic interventions. It is currently unclear to what extent biologically implausible...
7.
Peters S, Bots M, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, et al.
J Clin Epidemiol . 2012 Mar; 65(6):686-95. PMID: 22459429
Objective: To assess the added value of multiple imputation (MI) of missing repeated outcomes measures in longitudinal data sets analyzed with linear mixed-effects (LME) models. Study Design And Setting: Data...
8.
Peters S, Palmer M, den Ruijter H, Grobbee D, Crouse 3rd J, OLeary D, et al.
Curr Med Res Opin . 2012 Mar; 28(5):681-8. PMID: 22439736
Objective: Sample size calculations for clinical trials generally use expected changes between groups, and variances obtained from the literature. However, this approach neglects the impact of differences in trial design....
9.
Peters S, den Ruijter H, Palmer M, Grobbee D, Crouse 3rd J, OLeary D, et al.
J Am Soc Echocardiogr . 2011 Oct; 25(1):91-100. PMID: 21982737
Background: Ultrasound protocols to measure carotid intima-media thickness (CIMT) vary considerably with regard to carotid sites and angles that are assessed. Measurements from the carotid bifurcation and internal carotid artery...
10.
Dogan S, Plantinga Y, Crouse 3rd J, Evans G, Raichlen J, OLeary D, et al.
J Hypertens . 2011 Sep; 29(11):2181-93. PMID: 21918474
Background: Current ultrasound protocols to measure carotid intima-media thickness (CIMT) in trials differ considerably. The best CIMT protocol would be one that combines high reproducibility, a large and precise estimate...